In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $11.17 in the prior trading day, Chemours Company (NYSE: CC) closed at $11.18, up 0.09%. In other words, the price has increased by $0.09 from its previous closing price. On the day, 5.78 million shares were traded.
Ratios:
Our goal is to gain a better understanding of CC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.83 and its Current Ratio is at 1.75. In the meantime, Its Debt-to-Equity ratio is 7.57 whereas as Long-Term Debt/Eq ratio is at 7.39.
On January 28, 2025, Truist started tracking the stock assigning a Buy rating and target price of $27.
UBS Upgraded its Neutral to Buy on July 09, 2024, whereas the target price for the stock was revised from $28 to $30.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 07 ’24 when Scarborough Alvenia sold 7,500 shares for $20.64 per share. The transaction valued at 154,771 led to the insider holds 16,645 shares of the business.
Scarborough Alvenia bought 7,500 shares of CC for $150,000 on Nov 06 ’24. On Aug 07 ’24, another insider, Picho Diane I., who serves as the Interim Pres. – Titanium Tech of the company, sold 2,684 shares for $18.82 each. As a result, the insider received 50,519 and left with 19,890 shares of the company.
Valuation Measures:
As of this moment, Chemours’s Price-to-Earnings (P/E) ratio for their current fiscal year is 54.32, and their Forward P/E ratio for the next fiscal year is 4.58. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 2.89.
Stock Price History:
Over the past 52 weeks, CC has reached a high of $29.17, while it has fallen to a 52-week low of $9.33. The 50-Day Moving Average of the stock is -9.98%, while the 200-Day Moving Average is calculated to be -34.71%.
Shares Statistics:
A total of 149.57M shares are outstanding, with a floating share count of 148.48M. Insiders hold about 0.81% of the company’s shares, while institutions hold 93.65% stake in the company.
Earnings Estimates
Investors are keenly observing as 8.0 analysts analyze and rate the current performance of Chemours Company (CC) in the stock market.The consensus estimate for the next quarter is $0.57, with high estimates of $0.65 and low estimates of $0.45.
Analysts are recommending an EPS of between $2.0 and $1.35 for the fiscal current year, implying an average EPS of $1.65. EPS for the following year is $2.45, with 10.0 analysts recommending between $3.17 and $2.04.
Revenue Estimates
7 analysts predict $1.56B in revenue for the current quarter. It ranges from a high estimate of $1.59B to a low estimate of $1.53B. As of the current estimate, Chemours Company’s year-ago sales were $1.54BFor the next quarter, 7 analysts are estimating revenue of $1.55B. There is a high estimate of $1.58B for the next quarter, whereas the lowest estimate is $1.48B.
A total of 9 analysts have provided revenue estimates for CC’s current fiscal year. The highest revenue estimate was $5.96B, while the lowest revenue estimate was $5.75B, resulting in an average revenue estimate of $5.89B. In the same quarter a year ago, actual revenue was $5.78BBased on 9 analysts’ estimates, the company’s revenue will be $6.12B in the next fiscal year. The high estimate is $6.3B and the low estimate is $5.59B.
